Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

Patrick C. Walsh

doi:10.1016/j.juro.2010.05.078

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

Johns Hopkins Hospital

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	955
Number of pages	1
Journal	Journal of Urology
Volume	184
Issue number	3
DOIs	https://doi.org/10.1016/j.juro.2010.05.078
State	Published - Sep 2010

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2010.05.078

Cite this

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology. / Walsh, Patrick C.
In: Journal of Urology, Vol. 184, No. 3, 09.2010, p. 955.

Research output: Contribution to journal › Comment/debate › peer-review

@article{8d37fdfa3d8648ceaf60914c6b5edc77,

title = "Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology",

author = "Walsh, {Patrick C.}",

year = "2010",

month = sep,

doi = "10.1016/j.juro.2010.05.078",

language = "English (US)",

volume = "184",

pages = "955",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Androgen-deprivation therapy in prostate cancer and cardiovascular risk

T2 - A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

AU - Walsh, Patrick C.

PY - 2010/9

Y1 - 2010/9

UR - http://www.scopus.com/inward/record.url?scp=78049269997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049269997&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2010.05.078

DO - 10.1016/j.juro.2010.05.078

M3 - Comment/debate

AN - SCOPUS:78049269997

SN - 0022-5347

VL - 184

SP - 955

JO - Journal of Urology

JF - Journal of Urology

IS - 3

ER -

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this